// App-Quantinova.ai

1804 : Incidence, Management and Outcomes of Arterial and Venous Thromboembolism after Chimeric Antigen Receptor Modified T Cells for B-Cell Lymphoma and Multiple Myeloma

Researchers

Presenter

  • Anna L. Parks

Principal Investigators

  • Swetha Kambhampati

  • Bita Fakhri

  • Charalambos Andreadis

  • Lissa Gray

  • Sandy W. Wong

  • Nina Shah

  • Margaret C. Fang

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Division of Gynecologic Oncology, University of California, San Francisco, San Francisco, CA

  • Division of Rheumatology, University of California, San Francisco, CA

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • Division of General Pediatrics, University of California, San Francisco, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved